Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 38%
Buy 44%
Hold 19%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is well-positioned to capitalize on the growing healthcare industry, with its strong focus on providing efficient and affordable healthcare solutions. Its diversified business mix, which includes specialty drug capabilities and minimal exposure to government contracts, sets it apart from its peers and provides a strong foundation for long-term growth. The company's recent success in implementing AI technology and its commitment to sustainability also bode well for its future prospects, making it an attractive investment opportunity.

Bears say

Cigna Group is facing a negative outlook due to potential execution risks in managing medical cost trends and network contracting, as well as potential impact from regulatory changes on rebate economics. Additionally, a protracted economic downturn could affect the company's earnings growth trajectory. Although Cigna has taken actions to support its customers, employees, and the medical community during the pandemic, its PBM business may still face challenges and uncertainties. Overall, there is uncertainty surrounding the company's ability to execute in a complex operating environment, which could lead to negative surprises and affect its overall performance.

Cigna (CI) has been analyzed by 16 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 44% recommend Buy, 19% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 16 analysts, Cigna (CI) has a Buy consensus rating as of Jun 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $345.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $345.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.